CareMax 将来の成長

Future 基準チェック /26

CareMaxは、77.2%と26%でそれぞれ年率77.2%で利益と収益が成長すると予測される一方、EPSはgrowで101.9%年率。

主要情報

77.2%

収益成長率

101.9%

EPS成長率

Healthcare 収益成長	21.0%
収益成長率	26.0%
将来の株主資本利益率	n/a
アナリストカバレッジ	Low
最終更新日	18 Nov 2024

今後の成長に関する最新情報

US$2.60: That's What Analysts Think CareMax, Inc. (NASDAQ:CMAX) Is Worth After Its Latest Results

Aug 14

Recent updates

US$2.60: That's What Analysts Think CareMax, Inc. (NASDAQ:CMAX) Is Worth After Its Latest Results

Aug 14

CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Jun 20

Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

May 13

Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

Mar 11

CareMax: Numbers Are Strong, Compelling Value On Offer

Sep 16

CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M

Aug 09

CareMax: Steward Health Care Acquisition Highlights Growth Ambitions

Jul 02

業績と収益の成長予測

OTCPK:CMAX.Q - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	1,383	-72	N/A	N/A	1
12/31/2025	1,240	-151	N/A	N/A	1
12/31/2024	772	-130	N/A	N/A	1
6/30/2024	785	-783	-62	-52	N/A
3/31/2024	810	-645	-61	-49	N/A
12/31/2023	751	-683	-62	-47	N/A
9/30/2023	764	-207	-101	-91	N/A
6/30/2023	719	-126	-94	-84	N/A
3/31/2023	667	-103	-86	-78	N/A
12/31/2022	631	-38	-76	-68	N/A
9/30/2022	585	-52	-61	-55	N/A
6/30/2022	532	-44	-54	-48	N/A
3/31/2022	405	-25	-43	-39	N/A
12/31/2021	296	-7	-28	-24	N/A
9/30/2021	206	-2	-13	-9	N/A
6/30/2021	125	12	-4	-2	N/A
3/31/2021	106	6	5	7	N/A
12/31/2020	103	8	3	5	N/A
9/30/2020	101	7	5	8	N/A
12/31/2019	91	6	6	7	N/A
12/31/2018	72	3	0	1	N/A

アナリストによる今後の成長予測

収入対貯蓄率: CMAX.Q今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: CMAX.Q今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: CMAX.Q今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: CMAX.Qの収益 ( 26% ) US市場 ( 8.9% ) よりも速いペースで成長すると予測されています。

高い収益成長: CMAX.Qの収益 ( 26% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: CMAX.Qの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

CareMax 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Consensus EPS estimates fall by 125%, revenue upgraded

Consensus EPS estimates upgraded to US$20.83 loss, revenue downgraded

US$2.60: That's What Analysts Think CareMax, Inc. (NASDAQ:CMAX) Is Worth After Its Latest Results

Consensus EPS estimates upgraded to US$33.26 loss

Price target decreased by 42% to US$26.00

Price target decreased by 17% to US$37.33

Recent updates

CareMax, Inc.(OTCPK:CMAX.Q) dropped from NASDAQ Composite Index

CareMax, Inc.(NasdaqGS:CMAX) dropped from S&P TMI Index

Interim DIP Financing Approved for CareMax, Inc.

Interim DIP Financing Approved for CareMax, Inc.

CareMax, Inc. Filed for Bankruptcy

CareMax, Inc. announced delayed 10-Q filing

Consensus EPS estimates fall by 125%, revenue upgraded

High number of new directors

CareMax Receives Non-Compliance Notice from Nasdaq Regarding Minimum MVPHS Requirement

Consensus EPS estimates upgraded to US$20.83 loss, revenue downgraded

US$2.60: That's What Analysts Think CareMax, Inc. (NASDAQ:CMAX) Is Worth After Its Latest Results

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates upgraded to US$33.26 loss

New major risk - Financial position

High number of new directors

CareMax, Inc. announced delayed annual 10-K filing

Price target decreased by 42% to US$26.00

Price target decreased by 17% to US$37.33

CareMax Announces 1-for-30 Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement

CareMax Receives Non-Compliance Notice From Nasdaq

New major risk - Share price stability

New minor risk - Market cap size

Consensus EPS estimates fall by 64%

Price target increased by 9.1% to US$6.00

Consensus EPS estimates fall by 105%

New minor risk - Profitability

Caremax, Inc. Reports Unaudited Goodwill Impairment for the Three Months Ended September 30, 2023

CareMax, Inc. to Report Q3, 2023 Results on Nov 09, 2023

CareMax, Inc. Announces Resignation of David J. Shulkin as A Member of the Board of Director

Consensus EPS estimates fall by 18%, revenue upgraded

Price target decreased by 11% to US$6.00

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Caremax, Inc. Raises Revenue Guidance for the Full Year of 2023

CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Consensus EPS estimates upgraded to US$0.28 loss, revenue downgraded

Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

Caremax, Inc. Reaffirms Full Year 2023 Guidance

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates upgraded to US$0.42 loss

Consensus EPS estimates upgraded to US$0.49 loss, revenue downgraded

Consensus revenue estimates fall by 12%

Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to US$8.50

CareMax, Inc. Appoints Ralph De La Torre as Director

Consensus forecasts updated

High number of new and inexperienced directors

CareMax, Inc. (NasdaqGS:CMAX) completed the acquisition of Steward National Care Network, Inc., Steward Integrated Care Network, Inc. and Steward Accountable Care Network, Inc. from Steward Health Care System LLC.

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Caremax, Inc. Raises Earnings Guidance for the Full Year 2022

CareMax, Inc. Approves Appointment of Ryan O'quinn as Board of Director

CareMax, Inc. to Report Q3, 2022 Results on Nov 09, 2022

CareMax, Inc., Annual General Meeting, Nov 02, 2022

CareMax: Numbers Are Strong, Compelling Value On Offer

Price target decreased to US$11.10

Consensus estimates of losses per share improve by 14%

Consensus forecasts updated

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

CareMax, Inc. Revises Earnings Guidance for the Full Year 2022

CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M

CareMax, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Price target decreased to US$11.00

High number of new and inexperienced directors

CareMax: Steward Health Care Acquisition Highlights Growth Ambitions

CareMax, Inc. (NasdaqGS:CMAX) entered into an agreement to acquire Steward National Care Network, Inc., Steward Integrated Care Network, Inc. and Steward Accountable Care Network, Inc. from Steward Health Care System LLC for approximately $135 million.

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率